Associate Director, Data and Analytics

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... consideration for employment without regard to race, ethnicity, color, religion, sex gender identity, sexual orientation, national...

Lugar: Waltham, MA | 12/12/2025 22:12:12 PM | Salario: S/. $171000 - 209000 per year | Empresa: Madrigal

Registered Nurse (RN) - Med Surg Stepdown

: 00004024 CLINICAL NURSE II Job Level: F2 Duke is an Equal Opportunity Employer committed to providing employment opportunity..., national origin, race, religion, sex (including pregnancy and pregnancy related conditions), sexual orientation or military...

Lugar: Raleigh, NC | 12/12/2025 18:12:40 PM | Salario: S/. No Especificado | Empresa: Duke University

Senior Manager, AI and Data Science

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial...

Lugar: Conshohocken, PA | 10/12/2025 00:12:19 AM | Salario: S/. $163000 - 200000 per year | Empresa: Madrigal

Senior Director, Commercial Patient Hub Data Operations

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra..., sexual orientation, national origin, age, disability, protected veteran or disabled status, or other characteristic protected...

Lugar: Conshohocken, PA | 07/12/2025 01:12:34 AM | Salario: S/. No Especificado | Empresa: Madrigal

Associate Director, Patient Support Solutions

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra..., sexual orientation, national origin, age, disability, protected veteran or disabled status, or other characteristic protected...

Lugar: Waltham, MA | 04/12/2025 19:12:23 PM | Salario: S/. $172000 - 210000 per year | Empresa: Madrigal

Director, Global Health Economics & Outcomes Research

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... gender identity, sexual orientation, national origin, age, disability, protected veteran or disabled status...

Lugar: Conshohocken, PA | 03/12/2025 20:12:06 PM | Salario: S/. No Especificado | Empresa: Madrigal

Senior Director, Global Scientific Content

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra..., sexual orientation, national origin, age, disability, protected veteran or disabled status, or other characteristic protected...

Lugar: Conshohocken, PA | 03/12/2025 01:12:33 AM | Salario: S/. No Especificado | Empresa: Madrigal